SoftFil®

SoftFil® Medical Aesthetics, a French company founded by aesthetic physician Dr Sandrine Sebban in 2009, is a pioneer in the aesthetics industry. The company, operating under the brand name SoftFil®, was among the first to introduce micro-cannulas for facial injections. SoftFil® is dedicated to creating a safe environment for physicians in the aesthetics industry. The team in France collaborates with a vast network of international distributors to enhance the injection experience in over 90 countries. They offer injectors a premium range of products and services, aiming to elevate industry standards worldwide.

Uncompromised Safety with SoftFil® Micro-Cannulas

SoftFil® Precision Micro-Cannulas are designed to offer injectors unparalleled safety while optimising patient comfort. Engineered with innovative features, they ensure precision while reducing procedural risks in facial and body aesthetic treatments.

Key safety-enhancing features include:

Enhanced patient comfort: Patients experience less pain and discomfort during and after cannula procedures than needles.

Atraumatic, rounded-tip design that minimises vascular complications and significantly reduces bruising and discomfort, allowing for faster recovery.

Reduced trauma: Participants reported fewer side effects on the micro-cannula side than on the needle side, including less pain, edemas, rednesses, hematomas

A clear orifice indicator for accurate product placement, ensuring precision in every injection.

A Luer-Lock base for secure syringe attachment, preventing accidental detachment and ensuring seamless application.

Centimetre graduations for precise depth control give injectors greater treatment delivery accuracy.

An extra-thin wall structure provides controlled and smooth injections for the perfect balance of flexibility and rigidity.

Siliconised stainless steel tubing enhances glide, reducing patient discomfort and making the procedure more seamless.

Lower risk in complications: 77% reduction in vascular occlusion rate.

Raising the Bar for Injection Safety with SoftFil® EasyGuide

The SoftFil® EasyGuide is a revolutionary device developed to increase the precision and safety of micro-cannula injections. Designed by physicians and validated by leading experts in the field, this smart pre-hole needle streamlines the injection process, ensuring safer and more predictable outcomes.

Its unique half-needle design, featuring a V-shaped groove, allows for seamless cannula guidance to the correct depth and direction, improving product placement accuracy while reducing tissue trauma.

Further enhancing safety, the ergonomic double-grip design ensures maximum stability, allowing practitioners greater control, regardless of their dominant hand. The device’s specialised surface treatment also promotes gentle contact with the skin, minimising trauma, bruising, and post-treatment swelling.

Additional benefits include:

Reduced patient discomfort and risk of complications

Optimised procedural precision

More predictable injection techniques

Advancing Safety and Reliability in Aesthetic Procedures

At the core of SoftFil®’s mission is developing medical devices that improve aesthetic results and minimise risks associated with injection procedures. Designed with both practitioner confidence and patient safety in mind, SoftFil® offers a comprehensive range of solutions:

SoftFil® Academy – A globally recognised training platform that educates medical professionals on safe and effective injection techniques, led by top experts in aesthetic medicine.

SoftFil® Precision – The industry’s most extensive selection of micro-cannulas, engineered for controlled, accurate, and minimally traumatic injections.

SoftFil® EasyGuide – An innovative pre-hole needle that simplifies cannula insertion, ensuring safer and more precise treatments.

SoftFil® Post-Act Solutions – A specialised post-procedure skincare line that supports healing and enhances patient comfort after aesthetic treatments.

A Commitment to Excellence: SoftFil® and Prollenium

In May 2022, SoftFil® became part of Prollenium Medical Technologies Inc., a strategic partnership that reinforces both brands’ commitment to advancing safety and efficacy in aesthetic medicine. Prollenium, renowned for its Revanesse® dermal filler range, shares SoftFil®’s mission of improving procedural outcomes through cutting-edge innovation and rigorous quality standards.

Ario Koshbin, Prollenium’s founder and CEO, described the acquisition as a “natural fit,” uniting two brands with a common goal—enhancing safety and performance in aesthetic procedures. The combination of SoftFil® medical devices and Revanesse® dermal fillers equips practitioners with superior tools to elevate safety and patient satisfaction.